Octomom Fertility Doctor Loses California State Medical License

Michael Kamrava, the doctor who gave Nadya “Octomom” Suelman the fertility treatments that turned the single, unemployed woman already dependent on food stamps for survival into a mother of 14 kids under age 12, has lost the right to practice medicine in the State of California. The state’s medical board revoked Kamrava’s certification on Wednesday after finding that the practitioner endangered “public safety” when he implanted Suleman with multiple embyros in 2008.

She became only the second woman in the United States to ever deliver a full-set of octuplets when her eight youngest children were born in Jan. 2009.

The California medical board found that Kamrava, who implanted 12 embryos into Suleman with eight of them resulting in live births, made an “extreme” departure from the standard of care recommended by the American Society for Reproductive Medicine (ASRM). The ASRM recommends that in patients under the age of 35, no more than two embryos should be transferred. At a hearing last year, the doctor attempted to defended himself by arguing that he was complying with Suleman’s wishes. He added that he was concerned that her fertility could be impaired and that she needed a large number of embryos to increase the chances of having a baby.

A baby to add to the six she’d already delivered thanks to his treatment.

The board is also unhappy with Kamrava’s treatment of two other patients.

One was a 48 year-old woman whom Kamrava implanted with seven embryos, using eggs donated by her daughter.

“Public protection is paramount. The board is not assured that oversight through probation is enough, and having weighed the above, has determined that revocation of respondent’s certificate is necessary to protect the public….This is not a one-patient case or a two-patient case; it is a three patient case, and the established causes of discipline include repeated negligent acts (all three patients), gross negligence (two patients) and inadequate records (one patient),” the board said in its report.

Kamrava’s license expires on July 1.